Journals / Türk Patoloji Dergisi / 2022 / Cilt: 38 - Sayı: 2

HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case

Pages
142–147
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

At this point, the importance of clinicopathological correlation becomes more evident, especially in the determination of the treatment protocol to be applied to the patient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Human herpes virus-8 (HHV-8) is linked to four lymphoproliferative diseases: primary effusion lymphoma, HHV-8 positive multicentric Castleman disease (MCD), HHV-8 positive diffuse large B cell lymphoma and HHV-8 positive germinotropic lymphoproliferative disorder (GLPD).
📊
Key Findings & Data:The diagnosis of HHV-8 associated lymphoproliferative diseases is quite challenging because each entity is rare and has a wide morphological spectrum.
💡
Conclusion & Impact:At this point, the importance of clinicopathological correlation becomes more evident, especially in the determination of the treatment protocol to be applied to the patient.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Human herpes virus-8 (HHV-8) is linked to four lymphoproliferative diseases: primary effusion lymphoma, HHV-8 positive multicentric Castleman disease (MCD), HHV-8 positive diffuse large B cell lymphoma and HHV-8 positive germinotropic lymphoproliferative disorder (GLPD). The diagnosis of HHV-8 associated lymphoproliferative diseases is quite challenging because each entity is rare and has a wide morphological spectrum. Our aim is to emphasize the overlapping histopathological features of MCD and GLPD as well as to underline the importance of clinicopathological correlation in case these two entities cannot be distinguished by pathological examination. We present here a case of an 82-year-old male patient who was examined for weight loss and multiple lymphadenopathy. Histopathological examination of the axillary lymph node revealed lymphoid follicle structures of varying shapes and sizes, including some atrophic germinal centers. Plasmablast-like cells were notable in some of these areas. HHV-8 and Epstein Barr Virus (EBV) positivity were noted in some of these cells and in a small number of cells in the mantle zone. Based on these findings; a diagnosis of “HHV-8 and EBV positive lymphoproliferative disease” was established. Since HHV-8 positive MCD and GLPD have similar histopathological features, it may not be possible to distinguish these two entities by histopathological examination only. At this point, the importance of clinicopathological correlation becomes more evident, especially in the determination of the treatment protocol to be applied to the patient.

🔖

Cite This Article

ÖZCAN, M. A., ÖZKAL, S., BÜLBÜL, G., GÜL, G. (2022). HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case. Türk Patoloji Dergisi, Cilt: 38 - Sayı: 2, 142–147. https://ajindex.com/articles/640337

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Courville EL, Sohani AR, Hasserjian RP, Zukerberg LR, Harris NL, Ferry JA. Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems. Am J Clin Pathol. 2014;142:816-29
  2. Guerrero C, Jain T, Kelemen K. HHV-8-associated lymphoproliferative disorders and pathogenesis in an HIVpositive patient. Case Rep Hematol. 2019;2019:4536157
  3. Chen CH, Liu HC, Hung TT, Liu TP. Possible roles of Epstein- Barr virus in Castleman disease. J Cardiothorac Surg. 2009;4:31
  4. Taris M, de Mascarel A, Riols M, Delwail V, Milpied N, Dubus P, Parrens M. KHSV/EBV associated germinotropic lymphoproliferative disorder: A rare entity, case report and review of the literature. Ann Pathol. 2014;34:373-7
  5. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, Knowles DM. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi’s sarcomaassociated herpes virus. Blood. 1996;88:645-56
  6. Dupin N, Diss TL, Kellam P, Tulliez Micheline, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406- 12. 7. van Rhee F, Greenway A, Stone K. Treatment of Idiopathic Castleman Disease. Hematol Oncol Clin North Am. 2018;32:89- 106
  7. Dispenzieri A, Fajgenbaum DC. Overview of castleman disease. Blood. 2020;135:1353-64
  8. Waterston A, Bower M. Fifty years of multicentric Castleman’s disease. Acta Oncol. 2004;43:698-704
  9. Wang H, Pittaluga S, Jaffe ES. Multicentric Castleman disease: Where are we now? Semin Diagn Pathol. 2016;33:294-306
  10. Bhavsar T, Lee JC, Perner Y, Raffeld M, Xi L, Pittaluga S, Jaffe ES. KSHV- and EBV-associated germinotropic lymphoproliferative disorder: New findings and review of the literature. Am J Surg Pathol. 2018;41:795-800
  11. Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabeçadas J, Dong HY, Harris NL, Chan JKC, Rees JW, Dogan A, Isaacson PG. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood. 2002;100:3415-8
  12. Swerdlow SH, Campo E, Harris N, Jaffe ES, Pileri SA, Stein H, Thiele J. World Health Organization Histological Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed. IARC Press; 2017
  13. Gonzalez-Farre B, Martinez D, Lopez-Guerra M, Xipell M, Monclus E, Rovira J, Garcia F, Lopez-Guillermo A, Colomo L, Campo E, Martinez A. HHV8-related lymphoid proliferations: A broad spectrum of lesions